| Literature DB >> 24801647 |
Barbara Banelli1, Anna Morabito1, Stefania Laurent2, Patrizia Piccioli3, Beatrice Dozin4, Massimo Ghio5, Paolo Antonio Ascierto6, Stefano Monteghirfo7, Antonella Marasco7, Vincenzo Ottaviano7, Paola Queirolo7, Massimo Romani1, Maria Pia Pistillo8.
Abstract
CTLA-4 expression/function can be affected by single nucleotide polymorphisms (SNPs) of CTLA-4 gene, which have been widely associated with susceptibility or progression to autoimmune diseases and cancer development. In this study, we analyzed six CTLA-4 SNPs (-1661A>G, -1577G>A, -658C>T, -319C>T, +49A>G, CT60G>A) in 197 DNA samples from 43 B-lymphoblastoid cell lines (B-LCLs), 40 systemic sclerosis (SSc) patients, 14 pre-analyzed melanoma patients and 100 Italian healthy subjects. Genotyping of -1661A>G, -1577G>A, -658C>T and CT60G>A was performed by newly developed multiplex pyrosequencing (PSQ) assays, whereas -319C>T and +49A>G by T-ARMS PCR and direct sequencing. Genotype/allele frequency were analyzed using χ(2) or Fisher exact test. Our study provides the first multiplex PSQ method that allows simultaneous genotyping of two CTLA-4 SNP pairs (i.e. -1661A>G/-658C>T and -1577G>A/CT60G>A) by two multiplex PSQ reactions. Herein, we show the CTLA-4 genotype distribution in the B-LCLs providing the first and best characterized cell line panel typed for functionally relevant CTLA-4 SNPs. We also report the significant association of the -1661A/G genotype, -1661 & -319 AC-GT diplotype and -319 & CT60 TG haplotype with susceptibility to SSc without Hashimoto's thyroiditis occurrence. Furthermore, we confirmed previous genotyping data referred to melanoma patients and provided new genotyping data for Italian healthy subjects.Entities:
Keywords: B-LCLs; CTLA-4 single nucleotide polymorphisms; Melanoma patients; Pyrosequencing; Sclerodermic patients
Mesh:
Substances:
Year: 2014 PMID: 24801647 DOI: 10.1016/j.humimm.2014.04.019
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850